Does Blue Cross Blue Shield Cover Dupixent?
The verdict
Covered on most plans
BCBS plans cover Dupixent on the specialty tier with prior authorization and step therapy, but there is no single 'Blue Cross Dupixent policy' — BCBS is a federation of 30-plus independent licensees, each with its own formulary, PBM relationship (Prime Therapeutics, CVS Caremark, Express Scripts, or OptumRx), and step-therapy sequence. Coverage is broad across commercial, Medicare Advantage-PD, and Medicaid lines; administrative friction and coinsurance are the real barriers. Verify on your state BCBS formulary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.
Key facts
BCBS is a federation of 30-plus independent licensees — there is no single national Blue Cross formulary; each state plan sets its own tier, step-therapy requirements, and specialty-pharmacy partner for Dupixent.
Blue Cross Blue Shield Association — Plan locator
Dupixent (dupilumab) is FDA-approved for six indications, including atopic dermatitis (age 6 months+), moderate-to-severe asthma (age 6+), chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and COPD with eosinophilic phenotype.
FDA drug labeling — Dupixent (dupilumab), Sanofi/Regeneron
The 2026 Medicare Part D out-of-pocket cap is $2,100; specialty biologic patients who reach it pay nothing further for covered drugs for the rest of the year.
CMS.gov — Medicare Part D benefit parameters 2026
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield covers Dupixent depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
BCBS Medicare Advantage and Part D plans: Dupixent is on the specialty tier with PA and step therapy. Members pay approximately 25-33% coinsurance after the deductible, capped at $2,100 for 2026 — the plan covers 100% of cost above that cap for the rest of the year. Per Sanofi/Regeneron, about 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under post-IRA catastrophic protections. The Dupixent MyWay copay card is not available to Medicare or Medicaid beneficiaries. When Dupixent is administered by a clinician in an office setting, it may shift to Medicare Part B (medical benefit) rather than Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer plans: Dupixent is covered on the specialty tier (Tier 4 or 5) with PA and indication-specific step therapy. Tier and PBM vary by BCBS licensee — many use Prime Therapeutics, while others use CVS Caremark, Express Scripts, or OptumRx. Step-therapy sequence for atopic dermatitis typically requires topicals and sometimes a systemic agent; for asthma, preferred biologics (Xolair, Nucala, Tezspire) depending on phenotype. The Dupixent MyWay copay card (Sanofi/Regeneron) can reduce cost to as little as $0 for eligible commercially insured patients. ACA/Individual marketplace BCBS plans also cover Dupixent on the specialty tier with PA where offered. Medicaid: BCBS-managed Medicaid covers Dupixent per state PDL with PA and step therapy; nominal cost-share. Medical vs. pharmacy benefit: primarily pharmacy-benefit self-injected; can flip to medical benefit when clinic-administered.
The 5 boxes you must tick to get approved
Commercial plans that will consider Dupixent require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Dupixent actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $3,993 per carton of 2 pre-filled pens (list price, Jan 2025 estimate); average retail approximately $5,350-$5,377 per month (estimate). Treat all cash figures as estimates — verify current pricing before use.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial specialty tier: typically 25-33% coinsurance (composite; exact percentage varies by BCBS licensee and plan design). Medicare Advantage/Part D: approximately 25-33% coinsurance after deductible, capped at $2,100 for 2026. Medicaid: nominal cost-share. Verify cost-share on your state BCBS plan documents.
Typical monthly copay once prior authorization is approved.
Bridge program
Dupixent MyWay copay program (Sanofi/Regeneron): as little as $0 per month for eligible commercially insured patients. Not available to Medicare, Medicaid, or other government-plan enrollees. Enroll at dupixent.com/myway or call 1-844-DUPIXENT.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Coinsurance varies by BCBS licensee, plan tier, and plan design. Confirm your exact cost-share on your plan's Summary of Benefits or by calling the member services number on your BCBS insurance card.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Go to your specific state BCBS plan's formulary — not a national BCBS page
There is no single Blue Cross formulary. Navigate to your state BCBS plan's website (e.g., bcbs.com locates your state plan) and use its drug-lookup or formulary search. Search for 'Dupixent' and 'dupilumab.' Note the tier, PA or step-therapy requirements, and the designated specialty pharmacy and PBM for your plan.
- 2
Have your specialist submit a Prior Authorization to the plan's PBM
Your allergist, dermatologist, pulmonologist, or gastroenterologist initiates the PA. Collect clinical documentation: diagnosis, prior treatment history demonstrating step-therapy completion, current disease severity, and relevant lab values. The PA is submitted to the licensee's PBM — Prime Therapeutics, CVS Caremark, Express Scripts, or OptumRx depending on your plan.
- 3
Enroll in Dupixent MyWay if you are commercially insured
If your BCBS plan approves Dupixent but the specialty-tier coinsurance is still high, enroll in the Dupixent MyWay copay program at dupixent.com/myway. For Medicare beneficiaries, the $2,100 (2026) Part D cap limits annual exposure; if you still need help, ask about Medicare Extra Help (Low Income Subsidy).
Options if Blue Cross Blue Shield won't cover Dupixent
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Topical corticosteroids and calcineurin inhibitors
For atopic dermatitis: required step-therapy agents before Dupixent. Most BCBS licensees require documented failure of topical steroids and often topical calcineurin inhibitors (tacrolimus, pimecrolimus) before a PA can be approved.
Xolair (omalizumab), Nucala (mepolizumab), Tezspire (tezepelumab)
For asthma: preferred biologics that some BCBS plans require as step therapy before Dupixent, depending on eosinophil count and phenotype. Step-therapy sequence varies by licensee.
JAK inhibitors (Rinvoq, Cibinqo)
Some BCBS plans require a JAK inhibitor trial for moderate-to-severe atopic dermatitis in adults before approving Dupixent. Check your specific BCBS licensee's atopic dermatitis PA criteria.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes, BCBS plans cover Dupixent on the specialty tier with prior authorization and step therapy — but there is no single BCBS Dupixent policy. BCBS is 30-plus independent licensees; the exact tier (Tier 4 vs 5), step-therapy drugs required, PBM (Prime Therapeutics, CVS Caremark, Express Scripts, or OptumRx), and specialty pharmacy all vary by your state plan. Coverage is broad; verify on your specific state BCBS formulary for exact terms.
Prime Therapeutics is the PBM for many BCBS licensees — including most BCBS plans affiliated through the Health Care Service Corporation (HCSC) family and others. However, some BCBS licensees use CVS Caremark, Express Scripts, or OptumRx. Your plan's Summary of Benefits or the drug-lookup on your state BCBS website will identify which PBM and specialty pharmacy manage Dupixent for your specific plan.
With BCBS commercial insurance, expect specialty-tier coinsurance of approximately 25-33%; the Dupixent MyWay copay card can reduce this to as low as $0 for eligible commercially insured patients. With a BCBS Medicare Advantage or Part D plan, coinsurance is approximately 25-33% after the deductible, capped at $2,100 for 2026. About 79% of Medicare Part D Dupixent recipients pay $0-$100 per month per Sanofi/Regeneron. Medicaid members pay nominal cost-share. Verify your specific plan's cost-share.
For atopic dermatitis, BCBS licensees typically require documented failure of or contraindication to topical corticosteroids and topical calcineurin inhibitors. Some licensees additionally require a trial of a systemic immunosuppressant (e.g., methotrexate, cyclosporine) or a JAK inhibitor for moderate-to-severe cases. The exact required sequence is in your state BCBS plan's medical or drug-management policy — ask your dermatologist's PA coordinator to confirm before submission.
Dupixent is primarily dispensed as a self-injected pharmacy-benefit drug through the plan's specialty pharmacy. However, when a clinician administers Dupixent in an office or infusion setting, coverage shifts to the medical benefit — billed under Part B for Medicare members or under the medical cost-share for commercial plans. Most patients receive Dupixent as a home self-injection under the pharmacy benefit.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Ambien? 2026 | Curex
Blue Cross Blue Shield covers generic zolpidem (Tier 1–2); brand Ambien is non-preferred. Quantity limits apply. Verify your specific BCBS plan for 2026.
Read moreDoes BCBS of Texas Cover Ozempic? 2026 Guide | Curex
BCBS Texas (HCSC) covers Ozempic for T2D with PA — not weight loss. HCSC shares PA with BCBS IL. TX Medicaid uses separate Star MCOs. Verify on BCBS TX.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.